Trials / Unknown
UnknownNCT03391245
Vitamin D Level and Risk of Infections in Cirrhotic Patients
Vitamin D Level and Risk of Infections in Cirrhotic Patients: Does it Have a Role?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It is widely known that vitamin D has an important role in calcium metabolism and bone mineralization. Its deficiency is related to rickets and osteomalacia in children and adults respectively. Vitamin D had a role in innate and acquired immunity. It increases innate defense and modulates lymphocytes activation, leading to a change toward a T2 helper response ). The role of vitamin D deficiency on the risk of bacterial infection among patients in intensive care units has been reported. An observational studies in children reported an association between low 25-OH vitamin D level and infectious viral diseases . The deranged metabolism of vitamin D in liver cirrhosis was first reported in the late '70s and was attributed mainly to impaired 25(OH)-vitamin D hydroxylation of the precursor vitamin D caused by impaired liver function. Low level of vitamin D was found independently to be associated with increased risk of bacterial infections in patients with liver cirrhosis. The observed relationship between the lack of vitamin D and the increase risk of mortality in cirrhotic patients could be attributed to bacterial infections. Thus, the association of low vitamin D levels with liver insufficiency and infections supports the use of vitamin D as a prognostic marker in the population of cirrhosis. Studies on the role of vitamin D as a risk factor for infections in patients with liver cirrhosis are not well studied in our locality(Upper Egypt).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 3- Serum 25-Hydroxy Vitamin D level will be measured by Competitive ELISA technique | Serum 25-Hydroxy Vitamin D level will be measured by Competitive ELISA technique using CALBIOTECH (A life science company) kit, Catalog No.: VD220B |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-01-15
- Completion
- 2018-02-15
- First posted
- 2018-01-05
- Last updated
- 2018-01-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03391245. Inclusion in this directory is not an endorsement.